For example, in 2021, Employers Health clients that cover AOMs and have prior authorizations spent $0.85 PMPM on obesity products, while those without any restrictions spent $1.08 PMPM
Proper dosing ensures that patients achieve optimal glycemic control and weight management, making it essential for healthcare providers and patients alike to be well-informed about dosage guidelines
Starting July 2026, a short-term program called the Medicare GLP-1 Bridge, designed as a bridge to the broader BALANCE model, will cover Wegovy, Zepbound and Foundayo for eligible Part D enrollees at a $50 monthly copayment
We also had an unrelated patient come in for a different procedure who was super skinny and in the kind of profession that you need to be super skinny maybe in the adult entertainment industry who was also on GLP-1s, right
Symptoms like heartburn, regurgitation, and discomfort were noted